deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT03970330

Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

A Randomized Double-Blind Placebo-Controlled Trial to Assess the Effectiveness of Low-Dose Naltrexone in Combination With Standard Treatment in Women With Chronic Pelvic Pain Secondary to Endometriosis

Sponsor: Milton S. Hershey Medical Center

Conditions Endometriosis
Interventions Naltrexone Norethindrone Acetate Placebo
Updated 16 times since 2019 Last updated: Oct 8, 2022 Started: Jan 16, 2020 Primary completion: Jun 21, 2021 Completion: Jun 21, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Original PI left institution, lack of funding to continue

Other terminated trials from Milton S. Hershey Medical Center

See all terminations from Milton S. Hershey Medical Center

Other Endometriosis trials with similar outcome

Browse all Endometriosis trials

A PHASE3 clinical study on Endometriosis, this trial is terminated or withdrawn. The trial is conducted by Milton S. Hershey Medical Center and has accumulated 16 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Mar 2020 · 3 months · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~May 2022 · 7 months · monthly snapshot~May 2022 – ~Dec 2022 · 7 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE3

    Status: Recruiting → Terminated

  5. May 2022 — Dec 2022 [monthly]

    Recruiting PHASE3

▶ Show 11 earlier versions

  1. Oct 2021 — May 2022 [monthly]

    Recruiting PHASE3

  2. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  3. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Active Not Recruiting → Recruiting

  4. May 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  5. Mar 2020 — May 2020 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  6. Dec 2019 — Mar 2020 [monthly]

    Not Yet Recruiting PHASE3

  7. Nov 2019 — Dec 2019 [monthly]

    Not Yet Recruiting PHASE3

  8. Oct 2019 — Nov 2019 [monthly]

    Not Yet Recruiting PHASE3

  9. Aug 2019 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE3

  10. Jul 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE3

  11. Jun 2019 — Jul 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Milton S. Hershey Medical Center
Data source: Milton S. Hershey Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations